Senior Director, Business Development

About Us:

Structure Therapeutics develops life‐changing medicines for patients using advanced structure‐based and computational drug discovery technology. The company’s platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs. We are advancing a clinical‐stage pipeline of differentiated treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic, and pulmonary conditions.

Structure Therapeutics is led by an experienced group of international drug innovators and financed by top-tier global life sciences investors. The company completed an initial public offering (IPO) in February 2023. With offices in California and Shanghai, Structure Therapeutics has the benefit of being at the center of life science innovation in both the US and China and capitalizing on the strengths of each geographic location.

Position Summary:

Structure Therapeutics is seeking a Senior Director, Business Development to support the company’s strategic growth through high-impact external innovation, in-licensing, partnering, and transaction execution. This individual will play a key role in identifying, evaluating, and advancing business development opportunities that align with Structure’s therapeutic strategy and pipeline priorities.

The ideal candidate will bring deep business development transaction experience, particularly from the sell side, with a strong understanding of pharmaceutical and biotechnology deal processes, asset positioning, diligence, valuation, and partner engagement. Dedicated sell-side experience involving lung disease, including idiopathic pulmonary fibrosis, pulmonary arterial hypertension, or broader fibrosis indications, is a strong plus. This individual should have an established external network across biotechnology, pharmaceutical companies, investors, bankers, advisors, academic innovators, and other relevant ecosystem participants, and be able to proactively leverage that network to identify high-quality opportunities, access decision-makers, and generate actionable market intelligence.

 

Experience in metabolic disease is also highly valued.

This role requires a highly strategic and execution-oriented professional who can operate with a high degree of independence. The successful candidate will be a self-starter who can build structure around ambiguous opportunities, drive workstreams without heavy supervision, and move opportunities from initial identification through strategic assessment, diligence, recommendation, and execution. Strong scientific and clinical development fluency is critical, including the ability to understand disease biology, mechanism of action, preclinical and clinical data, development strategy, regulatory considerations, competitive positioning, and potential clinical differentiation.

Job Responsibilities:

• Provide sell-side expertise to help position assets, evaluate partnering strategies, and structure compelling external narratives for potential collaborators or counterparties.
• Proactively source and identify licensing opportunities and external innovation aligned with Structure Therapeutics’ strategic priorities, leveraging an established network of biopharma executives, investors, bankers, advisors, academic institutions, and other industry participants.
• Build and maintain productive relationships with biotechnology companies, pharmaceutical partners, venture investors, investment banks, scientific founders, key opinion leaders, and other external stakeholders to generate proprietary or differentiated deal flow.
• Support the identification, assessment, and execution of external innovation, in-licensing, partnering, and transaction opportunities.
• Lead or contribute to business development workstreams, including opportunity sourcing, strategic assessment, competitive landscape analysis, valuation, diligence, and transaction support.
• Independently drive business development projects from initial opportunity screening through internal recommendation, coordinating cross-functional input and maintaining momentum across multiple parallel workstreams.
• Apply scientific and clinical development judgment to evaluate asset quality, mechanism of action, translational rationale, clinical data packages, development plans, regulatory paths, and differentiation versus current and emerging standards of care.
• Partner closely with cross-functional teams to conduct scientific, clinical, commercial, financial, legal, and intellectual property diligence.
• Prepare high-quality presentations, investment memos, opportuni